Inventor · disambiguated record
Xiaocheng Chen
Also filed as: CHEN XIAOCHENG · CHEN XIAOCHENG CORA
32 granted patents·20 pending applications·220 citations·filing 2008–2025
97Inventor score
Files withGENENTECH INC27DENALI THERAPEUTICS INC12CHEN XIAOCHENG6VIRTUOSO BINCO INC5CHEN XIAOCHENG CORA1
Top patents by PatentIndex Score
52 records- 0198USD982355SPillowCHEN XIAOCHENG·Filed 2021·Granted Apr 4, 2023·70 cites·1 claims
- 0296US11912778B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·2 cites·17 claims
- 0396US10643711B1Workload based dynamic erase suspend adaptationWESTERN DIGITAL TECH INC·Filed 2018·Granted May 5, 2020·28 cites·17 claims
- 0496US9518118B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2015·Granted Dec 13, 2016·22 cites·29 claims
- 0595US10457717B2Engineered polypeptidesDENALI THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·11 cites·29 claims
- 0694US10865251B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Dec 15, 2020·6 cites·20 claims
- 0793US12162948B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·1 cites·16 claims
- 0892US10752703B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2019·Granted Aug 25, 2020·7 cites·28 claims
- 0991US10174124B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jan 8, 2019·11 cites·14 claims
- 1090USD1035943SFlashlightCHEN XIAOCHENG·Filed 2024·Granted Jul 16, 2024·11 cites·1 claims
- 1190US10179820B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2016·Granted Jan 15, 2019·6 cites·26 claims
- 1288US11795232B2Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2019·Granted Oct 24, 2023·2 cites·38 claims
- 1388US2024141058A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1487US10640572B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2017·Granted May 5, 2020·2 cites·18 claims
- 1587US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 1687US2024018253A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1785US11732054B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Aug 22, 2023·1 cites·56 claims
- 1885US11530275B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 1985US10738131B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2018·Granted Aug 11, 2020·2 cites·45 claims
- 2085US2025297023A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2184US12466896B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2022·Granted Nov 11, 2025·0 cites·31 claims
- 2283US11939396B2Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2020·Granted Mar 26, 2024·1 cites·33 claims
- 2383US11186650B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Nov 30, 2021·1 cites·79 claims
- 2483US10556966B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2018·Granted Feb 11, 2020·2 cites·44 claims
- 2583US2024043831A1Expression and secretion systemGENENTECH INC·Filed 2023·Application pending·0 cites
- 2682US12492263B2Anti-HER2 antibodies and immunoconjugatesGENENTECH INC·Filed 2022·Granted Dec 9, 2025·0 cites·15 claims
- 2782USD821006SHead lampCHEN XIAOCHENG·Filed 2016·Granted Jun 19, 2018·22 cites·1 claims
- 2882US2024368306A1Anti-tryptase antibodies, compositions thereof, and uses thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2982US2024024432A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3082US2024271326A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3179US10314846B2Immunoconjugates comprising anti-HER2 antibodies and pyrrolobenzodiazepinesGENENTECH INC·Filed 2017·Granted Jun 11, 2019·2 cites·64 claims
- 3277US2025333723A1Expression and secretion systemGENENTECH INC·Filed 2025·Application pending·0 cites
- 3375US2020255539A1Anti-HER2 Antibodies and ImmunoconjugatesGENENTECH INC·Filed 2019·Application pending·0 cites
- 3470US11370832B2Anti-Tau antibodies and methods of use thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Jun 28, 2022·1 cites·26 claims
- 3570US2020385704A1Expression and secretion systemGENENTECH INC·Filed 2020·Application pending·0 cites
- 3667US11732023B2Engineered polypeptidesDENALI THERAPEUTICS INC·Filed 2019·Granted Aug 22, 2023·0 cites·17 claims
- 3767US10633650B2Expression and secretion systemGENENTECH INC·Filed 2017·Granted Apr 28, 2020·0 cites·19 claims
- 3867US2020369746A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3965US9803191B2Expression and secretion systemGENENTECH INC·Filed 2013·Granted Oct 31, 2017·0 cites·39 claims
- 4063US11466087B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2019·Granted Oct 11, 2022·0 cites·17 claims
- 4155US8295288B2Registered state change notification for a fibre channel networkCHEN XIAOCHENG CORA·Filed 2008·Granted Oct 23, 2012·2 cites·14 claims
- 4254US2025171556A1Multispecific antibodies for treating cd47-associated diseasesVIRTUOSO BINCO INC·Filed 2022·Application pending·0 cites
- 4354US2015376265A1Antibody compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4453US2020085840A1Immunoconjugates Comprising Anti-HER2 Antibodies and PyrrolobenzodiazepinesGENENTECH INC·Filed 2019·Application pending·0 cites
- 4551US2024174750A1Anti-cd47 antibodies and uses thereofVIRTUOSO BINCO INC·Filed 2022·Application pending·0 cites
- 4649US2023312740A1Humanized cd38 and icam1 antibodies and uses thereofVIRTUOSO BINCO INC·Filed 2021·Application pending·0 cites
- 4748US2023183381A1Multispecific antibodies targeting cd38 and bcma and uses thereofVIRTUOSO BINCO INC·Filed 2021·Application pending·0 cites
- 4847US2023159663A1Bispecific antibodies for treating cd47-associated diseasesVIRTUOSO BINCO INC·Filed 2021·Application pending·0 cites
- 4946US2012082666A1Antibody compositions and methods of useCHEN XIAOCHENG·Filed 2011·Application pending·0 cites
- 5045USD1062972SFumigatorCHEN XIAOCHENG·Filed 2024·Granted Feb 18, 2025·0 cites·1 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →